Company profile

Ceevra

Medical Imaging & Radiology

Company profile

About Ceevra

Ceevra is a San Francisco-based medical software company that transforms surgical planning through AI-driven 3D imaging technology. Using FDA-cleared machine learning and computer vision algorithms, Ceevra generates detailed, interactive 3D digital models from CT and MRI scans that surgeons can view on phones, tablets, laptops, and surgical robotic displays. The platform supports numerous surgical specialties including thoracic, urologic, general, hepatopancreatobiliary (HPB), and gynecologic surgery, and is used in open, laparoscopic, and robotic procedures. Ceevra's models are generated entirely by the company using AI-driven software and in-house imaging technologists, requiring no effort from hospital personnel. The 3D models routinely and significantly impact how surgeons approach their operations, with two randomized clinical trials demonstrating substantial patient outcomes improvements. For robotic partial nephrectomy and robotic prostatectomy procedures, studies published in JAMA Network Open showed significant improvements in cancer control, erectile function, and rates of adjuvant therapy. The platform is purchased as an annual software subscription with various tiers based on anticipated volume, and can combine multiple surgical specialties and hospitals from the same health system. Ceevra's comprehensive coverage enables hospitals to offer 3D imaging to a broad spectrum of surgeons and patients, improving both surgical planning and patient counseling experiences.

Company description Ceevra official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Ceevra?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • cancer surgery
  • hepatopancreatobiliary conditions
  • kidney tumors
  • lung cancer
  • prostate cancer
  • thoracic oncology
  • uterine fibroids

Who it serves

  • Academic Medical Centers
  • Cancer Centers
  • Health Systems

Deployment & integration

Hybrid deployment with recorded integration context.

Recorded integration context: PACS.

Geographic context

MarketsEuropean Union · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance for AI-powered surgical planning 3D software (May 2023), EU MDR certification (June 2024), JAMA Network Open publication on prostatectomy outcomes (September 2024), AATS presentation on segmentectomy outcomes (September 2025)

Partnerships

Recorded partners

  • AdventHealth Celebration Hospital
  • Memorial Sloan Kettering Cancer Center
  • Providence Swedish
  • University of Alabama at Birmingham
  • University of Colorado Anschutz Medical Campus

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Ceevra 3D Surgical Imaging Platform

AI-driven 3D surgical planning models from CT/MRI scans

Software · HybridCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Trifecta Outcomes rates nearly 5x higher

robotic prostatectomy using Ceevra 3D models vs MRI alone

Improved cancer control

robotic prostatectomy procedures

Improved erectile function

robotic prostatectomy procedures

Reduced rates of adjuvant therapy

robotic prostatectomy procedures

Significant impact on surgical approach decisions

across multiple surgical specialties

Robotic Prostatectomy Clinical Trial

Surgical planning for robotic prostatectomy using Ceevra 3D models

Trifecta Outcomes rates nearly 5x higher than operations using only MRI; significantly improved cancer control, erectile function, and rates of adjuvant therapy

Providence Swedish

Surgical innovation and advances using Ceevra 3D models

Innovation and surgical advances for patients

Robotic Partial Nephrectomy Clinical Trial

Surgical planning for robotic partial nephrectomy using 3D virtual reality models

Substantial patient outcomes improvements demonstrated in randomized clinical trial

AdventHealth Celebration Hospital

Gynecological surgery myomectomy procedures with 3D imaging

Benefits practice and patient care

Memorial Sloan Kettering Cancer Center

Thoracic oncology surgical planning for segmentectomy and sublobar resection procedures

Described as 'indispensable to surgical planning' and 'huge advantage'

University of Alabama at Birmingham

Thoracic surgery planning - helps surgeons decide surgical approach and identify anatomical variations before entering OR

Saves time in OR by enabling pre-operative surgical approach planning

University of Colorado Anschutz Medical Campus

Thoracic surgery segmentectomy procedures using Ceevra 3D imaging

Significantly impacts surgical approach decisions

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Russ Yoshinaka

Russ Yoshinaka

Chief Executive Officer

LinkedIn

Ken Koster

Chief Technology Officer

LinkedIn

Joseph Shirk

Medical Director

Hanna Winter

Vice President of Engineering

LinkedIn

Connor Normand

Director of Engineering

LinkedIn

Alex Gilman

Senior Principal ML/CV Software Engineer

LinkedIn

06 · Company updates

Updates from Ceevra

Recent articles published on Ceevra's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon